Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 3, 2012, Pages

  Hutchens, Michael P ^a   Fujiyoshi, Tetsuhiro ^a   Komers, Radko ^a   Herson, Paco S ^a   Anderson, Sharon ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Cardiac arrest; Cardiopulmonary resuscitation; Estradiol; Estrogen; Gender; Ischemia reperfusion injury; Oxygen glucose deprivation; Renal ischemia; Sex

Indexed keywords

ADRENALIN; CREATININE; ESTRADIOL; ESTROGEN; FLUORESCEIN ISOTHIOCYANATE; G PROTEIN COUPLED RECEPTOR 30; GLUCOSE; OXYGEN; POTASSIUM CHLORIDE; RNA; SODIUM CHLORIDE; UREA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG IMPLANT; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; FEMALE; GENE SEQUENCE; GLOMERULUS; HEART ARREST; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MACROMOLECULE; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; RENAL PROTECTION; REOXYGENATION; REPERFUSION INJURY; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

EID: 84864772750     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00354.2011     Document Type: Article

References (48)

1. Akis N, Madaio MP. Isolation, culture, and characterization of endothe-lial cells from mouse glomeruli. Kidney Int 65: 2223-2227, 2004.
2. Andersson M, Nilsson U, Hjalmarsson C, Haraldsson B, Nystrom JS. Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier. Am J Physiol Renal Physiol 292: F1802-F1809, 2007.
3. Ardelt AA, McCullough LD, Korach KS, Wang MM, Munzenmaier DH, Hurn PD. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke 36: 337-341, 2005.
4. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 13: 1-7, 2004.
5. Basile DP, Friedrich JL, Spahic J, Knipe N, Mang H, Leonard EC, Changizi-Ashtiyani S, Bacallao RL, Molitoris BA, Sutton TA. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 300: F721-F733, 2011.
6. Benton J, Powers A, Eiselein L, Fitch R, Wilson D, Villablanca AC, Rutledge JC. Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability. Am J Physiol Regul Integr Comp Physiol 292: R723-R730, 2007.
7. Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285: F87-F94, 2003.
8. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343-348, 1998.
9. Cho MM, Ziats NP, Pal D, Utian WH, Gorodeski GI. Estrogen modulates paracellular permeability of human endothelial cells by eNOS-and iNOS-related mechanisms. Am J Physiol Cell Physiol 276: C337-C349, 1999.
10. Delarue F, Daunes S, Elhage R, Garcia A, Bayard F, Faye J. Estrogens modulate bovine vascular endothelial cell permeability and HSP 25 expression concomitantly. Am J Physiol Heart Circ Physiol 275: H1011-H1015, 1998.
11. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. In vivo effects of a GPR30 antagonist. Nat Chem Biol 5: 421-427, 2009.
12. Fink K, Schwarz M, Feldbrugge L, Sunkomat JN, Schwab T, Bourgeois N, Olschewski M, von Zur Muhlen C, Bode C, Busch J. Severe endothelial injury and subsequent repair in patients after successful car-diopulmonary resuscitation. Crit Care 14: R104, 2010.
13. Groten T, Pierce AA, Huen AC, Schnaper HW. 17 Beta-estradiol transiently disrupts adherens junctions in endothelial cells. FASEB J 19: 1368-1370, 2005.
14. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, Barton M. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49: 1358-1363, 2007.
15. Hamel MB, Phillips RS, Davis RB, Desbiens N, Connors AF, Teno JM, Wenger N, Lynn J, Wu AW, Fulkerson W, Tsevat J. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 127: 195-202, 1997.
16. Hutchens MP, Dunlap J, Nakano T, Traystman RJ, Hurn PD. Cardiac arrest-induced acute kidney injury is sexually dimorphic and mediated by estrogen (Abstract). Anesthesiology 107: A1857, 2007.
17. Hutchens MP, Nakano T, Dunlap J, Traystman RJ, Hurn PD, Al-kayed NJ. Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation. Resuscitation 76: 89-94, 2007.
18. Hutchens MP, Nakano T, Kosaka Y, Dunlap J, Zhang W, Herson PS, Murphy SJ, Anderson S, Hurn PD. Estrogen is renoprotective via a non-receptor dependent mechanism after cardiac arrest in vivo. Anesthe-siology 112: 395-405, 2010.
19. Hutchens MP, Dunlap J, Hurn PD, Jarnberg PO. Renal ischemia: does sex matter? Anesth Analg 107: 239-249, 2008.
20. Hutchens MP, Traystman RJ, Fujiyoshi T, Nakayama S, Herson PS. Normothermic cardiac arrest and cardiopulmonary resuscitation: a mouse model of ischemia-reperfusion injury. J Vis Exp. [Epub before print].
21. Keppler A, Gretz N, Schmidt R, Kloetzer HM, Groene HJ, Lelongt B, Meyer M, Sadick M, Pill J. Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int 71: 74-78, 2007.
22. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endo-thelin in vivo. J Clin Invest 83: 1762-1767, 1989.
23. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15: 1597-1605, 2004.
24. Lindsey SH, Carver KA, Prossnitz ER, Chappell MC. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol 57: 598-603, 2011.
25. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM, and Program to Improve Care in Acute Renal Disease. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 66: 1613-1621, 2004.
26. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30: 2051-2058, 2002.
27. Meyer MH, Meyer RA, Gray RW, Irwin RL. Picric acid methods greatly overestimate serum creatinine in mice: more accurate results with high-performance liquid chromatography. Anal Biochem 144: 285-290, 1985.
28. Muller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G, Tulassay T, Szabo AJ. Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int 62: 1364-1371, 2002.
29. Oliver JD, Anderson S, Troy JL, Brenner BM, Deen WH. Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol 3: 214-228, 1992.
30. Paganini EP, Halstenberg WK, Goormastic M. Risk modeling in acute renal failure requiring dialysis: the introduction of a new model. Clin Nephrol 46: 206-211, 1996.
31. Park KM, Cho HJ, Bonventre JV. Orchiectomy reduces susceptibility to renal ischemic injury: a role for heat shock proteins. Biochem Biophys Res Commun 328: 312-317, 2005.
32. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 279: 52282-52292, 2004.
33. Patschan D, Patschan S, Wessels JT, Becker JU, David S, Henze E, Goligorsky MS, Muller GA. Epac-1 activator 8-O-cAMP augments renoprotective effects of allogeneic murine EPCs in acute ischemic kidney injury. Am J Physiol Renal Physiol 298: F78-F85, 2010.
34. Remuzzi G. Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 4: 339-342, 1995.
35. Rippe C, Asgeirsson D, Venturoli D, Rippe A, Rippe B. Effects of glomerular filtration rate on Ficoll sieving coefficients (theta) in rats. Kidney Int 69: 1326-1332, 2006.
36. Rippe C, Rippe A, Larsson A, Asgeirsson D, Rippe B. Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 291: F1362-F1368, 2006.
37. Rosen S, Heyman SN. Difficulties in understanding human "acute tubular necrosis": limited data and flawed animal models. Kidney Int 60: 1220-1224, 2001.
38. Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Oku-mura K, Kitano K, Tsutsui H, Fujii K, Kobuchi S, Ohkita M, Matsumura Y. Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 73: 308-317, 2008.
39. Satchell SC, Anderson KL, Mathieson PW. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol 15: 566-574, 2004.
40. Sharma M, Zhou Z, Miura H, Papapetropoulos A, McCarthy ET, Sharma R, Savin VJ, Lianos EA. ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide. Am J Physiol Renal Physiol 296: F1386-F1395, 2009.
41. Shibata Y, Takaoka M, Maekawa D, Kuwahara C, Matsumura Y. Involvement of nitric oxide in the suppressive effect of 17beta-estradiol on endothelin-1 overproduction in ischemic acute renal failure. J Cardiovasc Pharmacol 44, Suppl 1: S459-S461, 2004.
42. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Moli-toris BA. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285: F191-F198, 2003.
43. Takaoka M, Yuba M, Fujii T, Ohkita M, Matsumura Y. Oestrogen protects against ischaemic acute renal failure in rats by suppressing renal endothelin-1 overproduction. Clin Sci (Lond) 103, Suppl 48: 434S-437S, 2002.
44. Triverio PA, Martin PY, Romand J, Pugin J, Perneger T, Saudan P. Long-term prognosis after acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 24: 2186-2189, 2009.
45. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, and Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818, 2005.
46. Vessey MP. Oral contraceptives and thromboembolic disease. Am Heart J 77: 153-157, 1969.
47. Voss MR, Stallone JN, Li M, Cornelussen RN, Knuefermann P, Knowlton AA. Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 285: H687-H692, 2003.
48. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006.